10-Q: Roadzen Narrows Losses, Boosts Revenue Amid Strategic Moves
Quarterly Report
Roadzen Inc. reported a significant reduction in net loss and increased revenue for the six months ended September 30, 2025, driven by strategic consolidations and reduced non-cash expenses, while actively managing liquidity and debt.
Summary
- Net loss attributable to ordinary shareholders significantly decreased to $6.11 million for the six months ended September 30, 2025, compared to $70.22 million in the prior year.
- Revenue increased by 18% to $24.54 million for the six months ended September 30, 2025, primarily due to the consolidation of the China VIE, Daokang, and expansion of the distribution network.
- Operating loss improved to $5.86 million for the six months ended September 30, 2025, from $53.94 million in the prior year.
- Adjusted EBITDA improved to a loss of $2.50 million for the six months ended September 30, 2025, compared to a loss of $4.95 million in the prior year.
- Non-cash expenses, particularly stock-based compensation, saw a substantial reduction from $46.98 million in the prior year to $0.13 million for the six months ended September 30, 2025.
- The company is engaged in a contractual dispute and legal proceedings with Meteora Capital Partners, LP regarding a Forward Purchase Agreement, alleging breach of contract, securities fraud, and RICO violations.
- Roadzen has an agreement in principle to extend the maturity date of its $11.5 million senior secured note with Mizuho Securities USA, LLC from December 31, 2025, to June 30, 2027.
- The company closed $7 million in India subsidiary financing in October 2025, resulting in approximately 8% dilution at the subsidiary level.
- A PIPE Purchase Agreement was executed in October 2025 to sell 1,200,000 Ordinary Shares for $1.5 million at $1.25 per share.
- Roadzen entered into a definitive agreement to acquire majority control of a commercial auto insurance broker and managing general underwriter (MGU) in October 2025, expanding its U.S. presence and Lloyds Coverholder status.
- The company continues to face liquidity challenges, with an accumulated deficit of $231.1 million as of September 30, 2025, and negative working capital, necessitating further capital raises and liability restructuring.
Sentiment
Score: 6
Explanation: While the company shows significant improvement in reducing net losses and growing revenue, and has made strategic moves like debt extension and acquisitions, substantial doubt about its going concern status remains due to accumulated deficit, negative working capital, and ongoing operating losses. The legal dispute and regulatory challenges also add uncertainty. The positive financial trends are strong, but the underlying financial health is still precarious.
Positives
- Significant reduction in net loss and operating loss for both the three and six months ended September 30, 2025, compared to the prior year.
- Revenue growth of 15% for the three months and 18% for the six months ended September 30, 2025, driven by consolidation of Daokang and distribution network expansion.
- Substantial decrease in non-cash stock-based compensation expenses, contributing to improved profitability metrics.
- Positive fair value gains in financial instruments ($556,194 for six months) compared to significant losses in the prior year.
- Successful closing of $7 million in India subsidiary financing and a $1.5 million PIPE investment.
- Agreement in principle to extend the maturity of the senior secured note with Mizuho to June 30, 2027, alleviating near-term debt pressure.
- Strategic acquisition agreement for a commercial auto insurance broker/MGU, expanding market reach and capabilities in the U.S. and with Lloyds of London.
- Improved net cash used in operating activities, decreasing by $2.3 million for the six months ended September 30, 2025.
Negatives
- Continued accumulated deficit, increasing to $231.1 million as of September 30, 2025.
- Negative operating cash flows and negative working capital position, raising substantial doubt about the company's ability to continue as a going concern.
- Increase in total current liabilities to $61.29 million as of September 30, 2025.
- Increase in interest expense by 51% for the six months ended September 30, 2025, due to increased borrowings.
- Contractual dispute and ongoing legal proceedings with Meteora Capital Partners, LP regarding the Forward Purchase Agreement, including allegations of securities fraud and RICO violations.
- Failure to honor repayment of secured debentures as of their amended maturity date, requiring an extension until November 30, 2025, and new negotiations for settlement.
- Promissory notes and convertible promissory notes remain unpaid on their due dates.
- The consolidation of the China joint venture (Daokang) is based on board control rather than majority equity ownership, posing risks of losing control or requiring deconsolidation due to changes in governance or regulation.
- The unaudited financial information of the newly consolidated Daokang is preliminary, and a Purchase Price Allocation (PPA) valuation has not yet been conducted, which may lead to changes in fair valuation.
- Sales of the Guaranteed Asset Protection (GAP) product in the U.K., a key contributor, were paused by the FCA, significantly impacting revenue and profitability in that segment.
Risks
- Ability to generate sufficient revenue to achieve and sustain profitability.
- Ability to raise sufficient capital to support operations and growth, and accurately predict future capital needs.
- Substantial regulation and potential for unfavorable changes or failure to comply with regulations.
- Management team's limited experience managing a public company.
- Significant increased expenses and administrative burdens as a public company.
- Risk of not agreeing on definitive agreements to extend the maturity date of the debt facility with the senior lender (Mizuho).
- Risk that the planned acquisition of majority control of a U.S.-based commercial auto insurance broker may not be completed on anticipated timetable or at all.
- Unaudited financial information of the newly consolidated entity (Daokang) is preliminary and actual financial condition and results may differ materially.
- Exposure to significant geopolitical, regulatory, and economic risks from the newly consolidated joint venture in China, including US-China and China-India tensions, trade restrictions, and data privacy regulations.
- Risk of not receiving consistent, complete, or reliable financial and operational information from the China joint venture, potentially leading to material misstatements, impairments, or write-offs.
- Risk of losing control or requiring deconsolidation of the China joint venture due to changes in governance, regulation, or local enforcement, as consolidation is based on board control rather than majority equity ownership.
- Dependence on the reliability, availability, and security of the technology platform and data, with risks of disruptions, security breaches, or data disclosure.
- Softening of the auto insurance market due to competition or regulation could negatively impact commission-based revenues.
- Regulatory actions or changes in India (IRDAI), UK (FCA), and US (CDI) could adversely affect business, increase compliance costs, or result in penalties.
Future Outlook
The company expects to continue experiencing operating losses and negative cash flows in the near future due to planned investments in its business. It anticipates needing additional capital to support strategic initiatives and growth. Management believes its plan to obtain sufficient liquidity through additional funds, equity raises, and liability restructuring is viable, expecting to alleviate substantial doubt regarding its ability to continue as a going concern. Roadzen aims to expand into new markets, continuously innovate its technology, and invest in partnerships for insurance offerings and fleet sales.
Management Comments
- Management believes it has formulated and is executing a viable plan to obtain sufficient liquidity to meet obligations as they fall due over the next 12 months.
- Management expects to alleviate the substantial doubt regarding the Company’s ability to continue as a going concern.
- We continue to develop and invest in our technology platform to drive scalability and build innovative products.
- We plan to continue investing in each of these channels of growth including hiring sales personnel, event marketing and global travel.
- We believe this presents an exciting and large opportunity to build insurance for this evolving environment.
- We intend to consistently offer cutting edge technology at the intersection of mobility and insurance a capability that traditional insurance carriers and other insurance intermediaries have struggled to provide.
- Roadzen is committed to maintaining a rigorous compliance posture to meet the FCA’s expectations for MGAs.
Industry Context
Roadzen operates in the rapidly evolving Insurtech sector, leveraging AI, telematics, and computer vision to transform auto insurance. Its focus on a capital-light business model (not underwriting risk) aligns with a trend towards technology-driven service provision rather than traditional risk-bearing. The company's global operations and partnerships with major insurers and OEMs (AXA, SCOR, Jaguar Land Rover, Audi, Mercedes, Volvo) indicate a strong position within the industry. The emphasis on AI research and development, including being a founding member of the AI Alliance, positions Roadzen at the forefront of technological innovation in insurance and mobility. However, the company faces challenges from a softening insurance market and stringent, evolving regulatory environments across India, the UK (e.g., FCA's pause on GAP product sales), and the U.S., which can impact revenue and operational flexibility. The planned acquisition of a U.S.-based commercial auto insurance broker/MGU suggests a strategy to deepen market penetration and expand underwriting capabilities in key geographies.
Comparison to Industry Standards
- The company's AI-driven approach to underwriting, distribution, claims, and road safety, including products like Via, GDN, xClaim, StrandD, Good Driving, DrivebuddyAI, and MixtapeAI, positions it as an innovator compared to traditional insurance models.
- Roadzen's recognition as "Worlds Top InsurTech by CNBC in 2024" and "Most Innovative Use of AI by Financial Express at the FE Futech Awards 2024" suggests strong industry standing in innovation, comparable to leading technology-focused insurance players.
- The capital-light business model, where Roadzen does not underwrite risk, contrasts with traditional insurance carriers like AXA or SCOR, focusing instead on technology and service provision.
- The company's global presence and partnerships with major automotive OEMs (Jaguar Land Rover, Audi, Mercedes, Volvo) and insurers (AXA, SCOR, Socit Gnrale) indicate a competitive advantage in embedded and B2B2C insurance distribution, a growing trend in the auto industry.
- The challenges faced with the FCA's pause on GAP product sales in the U.K. highlight the significant regulatory hurdles that Insurtechs, particularly MGAs, must navigate, which can be more dynamic than for traditional, fully licensed insurers.
- The ongoing legal dispute with Meteora Capital Partners, LP, involving allegations of securities fraud and RICO violations, is a significant deviation from standard industry practices and could impact investor confidence and operational focus.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Ms. Supurna VedBrat | 2024-03-28 | Entered into a securities purchase agreement and received warrants. |
| Director | NA | Ajay Shah | 2024-03-28 | Trustee of the general partner of Krishnan-Shah Family Partners, LP, which entered into a securities purchase agreement and received warrants. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- Roadzen filed a lawsuit against Meteora Capital Partners, LP in Florida on April 17, 2025, alleging willful breach of contract related to a Forward Purchase Agreement.
- Meteora filed a counterclaim against Roadzen in Delaware on April 18, 2025, alleging breach of registration obligations by Roadzen and seeking specific performance and damages.
- Roadzen filed an expanded lawsuit in the U.S. District Court for the Southern District of New York on September 23, 2025, alleging securities fraud and violations of the Racketeer Influenced and Corrupt Organizations Act (RICO) by Meteora.
- Roadzen voluntarily discontinued the Florida case on October 17, 2025, to consolidate it with the New York action.
- Meteora's request for default judgment against Roadzen in the District Court for the District of Delaware was denied on November 6, 2025.
Related Party Transactions
- Advances to employees include related party balances of $76,808 as of September 30, 2025, and $71,382 as of March 31, 2025.
- Accrued expenses include related party balances totaling $410,000 as of September 30, 2025, and $100,000 as of March 31, 2025.
- Amounts Due to Employees, comprising salary and reimbursement payables, include related party balances of $38,720 as of September 30, 2025, and $74,062 as of March 31, 2025.
- Ms. Supurna VedBrat, a director, and Krishnan-Shah Family Partners, LP (where director Ajay Shah and his wife are trustees) are parties to the March 2024 SPA, purchasing $500,000 each in 2024 SPA Notes and receiving warrants. Ms. VedBrat also purchased an additional $500,000 in 2024 SPA Notes.
- Ms. Supurna VedBrat, a director, received a $500,000 convertible debenture under the December 2023 Convertible SPA.
- Roadzen Technologies Private Limited (RZT) secured loan facilities from Cambridge Innovations Private Limited ($0.27 million) which was converted into equity capital of RZT on October 7, 2025.
Stakeholder Impact
- Shareholders: Potential for dilution from ongoing capital raises (India subsidiary financing, PIPE, potential future equity sales) and conversion of debentures/warrants. The significant reduction in net loss and revenue growth could be positive, but the accumulated deficit and going concern doubt remain concerns. The legal dispute with Meteora introduces uncertainty regarding share value and company reputation.
- Employees: Stock-based compensation is a component of employee benefits, and the extension of RSU vesting periods could impact employee retention or motivation.
- Customers: The company's focus on AI-powered solutions aims to improve customer experience (faster policy, claims processing). Regulatory changes, like the FCA's pause on GAP products, can directly impact product availability and service offerings to customers.
- Suppliers/Creditors: Delays in debt repayment and ongoing negotiations with lenders (e.g., secured debentures, Mizuho notes) indicate potential risks for creditors. The extension of the Mizuho note maturity provides some relief.
- Regulatory Authorities: The company's operations are subject to strict oversight in multiple jurisdictions, and non-compliance could lead to penalties or operational restrictions.
Next Steps
- Agree on definitive agreements to extend the maturity date of the debt facility with the senior lender (Mizuho).
- Complete the acquisition of majority control of a U.S.-based commercial auto insurance broker and managing general underwriter (MGU) within the current quarter.
- Conduct a Purchase Price Allocation (PPA) valuation of the newly consolidated China joint venture, Daokang.
- Continue negotiations to settle principal, accrued interest, and late payment charges for secured debentures, partly in cash and partly in equity of the Indian subsidiary.
- File a registration statement covering the resale of Ordinary Shares sold pursuant to the PIPE Purchase Agreement on or before December 31, 2025.
- Continue efforts to raise additional funds from existing or new credit facilities and/or additional share capital.
- Restructure existing liabilities, including converting current liabilities into equity or long-term notes.
- Monitor and adapt to evolving regulatory environments in India, the U.K., and the U.S.
- Address the contractual dispute and legal proceedings with Meteora Capital Partners, LP.
Key Dates
| Date | Description |
|---|---|
| 2017-07-31 | Roadzen (DE) entered into a joint venture with WI Harper VIII LLP and Shangrao Langtai Daokang Information Technology Co. Ltd. (Daokang). |
| 2023-06-30 | Roadzen (DE) entered into a $7.5 million senior secured notes agreement with Mizuho Securities USA LLC. |
| 2023-09-18 | Roadzen (DE) granted 9,903,500 RSUs under the 2023 Omnibus Incentive Plan. |
| 2023-09-20 | Vahanna, Roadzen (DE), and Merger Sub consummated the Business Combination; Vahanna changed its name to Roadzen Inc. |
| 2023-09-21 | Roadzen's ordinary shares and Public Warrants began trading on Nasdaq under RDZN and RDZNW. |
| 2023-10-20 | Public Warrants became exercisable. |
| 2023-12-15 | Company held initial closing of December 2023 Private Placement, receiving $400,000 in proceeds from convertible debentures. |
| 2024-01-19 | Company issued an additional $500,000 convertible debenture to Ms. Supurna VedBrat. |
| 2024-02-07 | Company issued an additional $200,000 convertible debenture. |
| 2024-03-28 | Company entered into a securities purchase agreement (March 2024 SPA) with Supurna VedBrat and Krishnan-Shah Family Partners, LP, for $500,000 each in 2024 SPA Notes. |
| 2024-04-22 | Company issued March 2024 SPA Warrants to purchase 50,000 Ordinary Shares to Krishnan-Shah Family Partners, LP. |
| 2024-05-14 | Company issued a warrant to Mizuho to purchase 1,432,517 Ordinary Shares as required by senior secured notes agreement. |
| 2024-05-23 | Ms. VedBrat purchased an additional $500,000 in principal amount of 2024 SPA Notes. |
| 2024-06-20 | Company issued March 2024 SPA Warrants to purchase 50,000 Ordinary Shares to Ms. VedBrat. |
| 2024-07-26 | Company entered into Amendment No. 1 to the senior secured notes, providing an additional $4 million and extending maturity to December 31, 2024. |
| 2024-09-19 | Lock-up legends were removed effective close of market. |
| 2024-09-30 | Company entered into an amendment agreement restructuring principal repayments and extending maturity date of Secured, Non-Convertible Debentures to March 31, 2025. |
| 2024-10-27 | Company issued additional March 2024 SPA Warrants to purchase 50,000 Ordinary Shares to Ms. VedBrat. |
| 2024-12-15 | Company entered into an underwriting agreement with ThinkEquity LLC and issued warrants to purchase 115,000 shares. |
| 2024-12-31 | Mizuho granted a waiver of payment until January 31, 2025. |
| 2025-01-03 | Company entered into a placement agent agreement with ThinkEquity LLC and issued warrants to purchase 111,115 shares. |
| 2025-01-31 | Mizuho granted a waiver of payment until February 28, 2025. |
| 2025-02-28 | Company entered into Amendment No. 2 to the Note Purchase Agreement with Mizuho, extending maturity to December 31, 2025, and issued an amended and restated warrant. |
| 2025-03-31 | Company entered into a securities purchase agreement with an institutional investor for junior convertible notes up to $2.3 million. |
| 2025-04-01 | Company completed the sale of Junior Notes to the Junior Investor. Roadzen reaffirmed board, governance, and management control of Daokang, enabling consolidation retroactive to this date. |
| 2025-04-10 | National Automobile Club (NAC) entered into an agreement with Libertas Funding, LLC to sell $774,000 of future receipts for $588,000. |
| 2025-04-17 | Roadzen filed a lawsuit in Palm Beach County, Florida against Meteora Capital Partners, LP alleging willful breach of contract related to a Forward Purchase Agreement. |
| 2025-04-18 | Meteora filed a separate lawsuit against the Company in the Court of Chancery of the State of Delaware. |
| 2025-05-23 | Company removed the pending action to the District Court for the District of Delaware. |
| 2025-06-03 | Meteora moved to remand the action back to the Court of Chancery and subsequently sought default judgment against the Company. |
| 2025-08-07 | National Automobile Club, Inc. (NAC) entered into a Junior Business Loan and Security Agreement with Agile Lending, LLC for $1.575 million. |
| 2025-09-17 | Revised vesting date for RSUs (originally Sept 17, 2024, then extended to Sept 17, 2025, and now to Sept 17, 2026). |
| 2025-09-23 | Company filed a lawsuit in the United States District Court for the Southern District of New York (USDC NY) alleging securities fraud and RICO violations by Meteora. |
| 2025-09-24 | Company filed an answer in opposition to the motion for default judgment with the District Court. |
| 2025-09-30 | End of the quarterly period covered by this report. |
| 2025-10-06 | Company announced the final closing of its India subsidiary financing, raising $7 million. |
| 2025-10-07 | Company converted principal due and all accrued interest from Cambridge Innovations Private Limited loan into equity capital of RZT. |
| 2025-10-08 | Company entered into a PIPE Purchase Agreement with an institutional investor for 1,200,000 Ordinary Shares for $1.5 million. |
| 2025-10-17 | Company filed a voluntary discontinuance of the Florida case against Meteora and thereafter filed an amended complaint in USDC NY. |
| 2025-10-29 | Company announced a definitive agreement to acquire majority control of a commercial auto insurance broker and managing general underwriter (MGU). |
| 2025-11-04 | Company announced an agreement in principle with Mizuho Securities USA, LLC to extend the maturity date of its senior secured note to June 30, 2027. |
| 2025-11-06 | District Court for the District of Delaware denied Meteora's request for default judgment. |
| 2025-11-12 | Date as of which 79,195,068 Ordinary Shares were issued and outstanding. |
| 2025-11-13 | Date of filing of this Quarterly Report on Form 10-Q. |
| 2025-12-15 | Maturity date for December 2023 Convertible Debentures. |
| 2025-12-31 | Target date for filing a registration statement covering the resale of Ordinary Shares from the PIPE Purchase Agreement. |
| 2026-03-06 | Maturity date for Junior Business Loan and Security Agreement with Agile Lending, LLC. |
| 2026-09-17 | Extended vesting date for most RSUs. |
| 2027-06-30 | Extended maturity date for Mizuho senior secured note (agreement in principle). |
| 2030-01-01 | Start of expiration period for federal net operating loss carry forwards generated prior to 2018 tax year. |
| 2031-03-28 | Expiration date for March 2024 SPA Warrants. |
| 2032-01-01 | Start of expiration period for state (Delaware) net operating loss carry forwards. |
Recommendation
holdWhile Roadzen has demonstrated significant improvements in reducing net losses and growing revenue, alongside strategic moves like debt extensions and acquisitions, the company still faces substantial liquidity challenges, including a large accumulated deficit and negative working capital, which raise going concern doubts. The ongoing legal dispute with Meteora and the preliminary nature of the China JV consolidation add considerable uncertainty. The positive operational trends are encouraging, but the underlying financial fragility and external risks warrant a cautious "hold" stance until there is clearer evidence of sustained profitability, resolved legal issues, and a stronger balance sheet.
Keywords
Insurtech, AI, Auto Insurance, Financial Technology, SEC Filing, 10-Q, Roadzen, RDZN, Financial Results, Debt Restructuring, Capital Raise, Acquisition, China Joint Venture, Mizuho, Meteora, Legal Proceedings, Corporate Governance, Risk Management, Financial Performance, Operating Loss, Revenue Growth, Stock-Based Compensation, Liquidity, Going Concern
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.